Sotera Health CoSHC +2.43%74 Current Ratio is 2.82 as of Mar. 2026, which is 14% above its 10-year median of 2.47. GuruFocus rates SHC with a GF Score™ of 74/100 and a GF Value™ of $16.31 (Fairly Valued). The stock has 3 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Sotera Health Co ranks better than 65.58% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sotera Health Co's current ratio for the quarter that ended in Mar. 2026 was 2.82.
Sotera Health Co has a current ratio of 2.82. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sotera Health Co's Current Ratio or its related term are showing as below:
SHC'
s Current Ratio Range Over the Past 10 Years
Min: 0.81 Med: 2.47 Max: 3.2
Current: 2.82
During the past 8 years, Sotera Health Co's highest Current Ratio was 3.20. The lowest was 0.81. And the median was 2.47.
SHC's Current Ratio is ranked better than 65.58% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96
vs SHC: 2.82
Sotera Health Co (NAS:SHC) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sotera Health Co Current Ratio Related Terms
Sotera Health Co Current Ratio Historical Data
* Premium members only.
The historical data trend for Sotera Health Co's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Sotera Health Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotera Health Co Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sotera Health Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotera Health Co (SHC) has a Current Ratio of 2.82 as of Mar. 2026. This is 14% above median its historical median of 2.47. Over the past decade, Sotera Health Co's Current Ratio has ranged from 0.81 to 3.20. According to the industry distribution chart, Sotera Health Co ranks #74 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 34.4%.
Is Sotera Health Co's Current Ratio too high?
Sotera Health Co's current Current Ratio of 2.82 is 14% above median its 10-year median of 2.47. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 3.20. The Medical Diagnostics & Research industry median Current Ratio is 1.96. Sotera Health Co's value of 2.82 is 43.9% above this industry median. Based on the distribution chart, Sotera Health Co ranks #74 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Sotera Health Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's Current Ratio compare to BLLN and RDNT?
According to the Medical Diagnostics & Research industry distribution chart, Sotera Health Co ranks #74 out of 215 companies for Current Ratio. This puts Sotera Health Co in the upper half of its industry. The industry median Current Ratio is 1.96. Sotera Health Co's value of 2.82 is 43.9% above this benchmark. Historically, Sotera Health Co's own Current Ratio has ranged from 0.81 to 3.20 over the past decade. While the company's 10-year median is 2.47 vs. the industry median of 1.96, Sotera Health Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 1.96, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sotera Health Co's current Current Ratio of 2.82 is 43.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotera Health Co's current Current Ratio is 2.82, which is 14% above median its own 10-year median of 2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.31, compared to a current price of $17.10 — trading 4.8% above its estimated fair value. The current Current Ratio is 2.82, which is 14% above median its 10-year median of 2.47 and 43.9% above the Medical Diagnostics & Research industry median of 1.96. Sotera Health Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sotera Health Co (SHC), the current Current Ratio is 2.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sotera Health Co (SHC) Overvalued in 2026?
Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued.
The current stock price of $17.10 is trading 4.8% above its estimated GF Value™ of $16.31.
GuruFocus considers Sotera Health Co to be Fairly Valued.
Key valuation signals for SHC:
Current Ratio: 2.82 (14% above median its 10-year median of 2.47)
GF Value™: $16.31 vs. price of $17.10 (4.8% above fair value)
Industry Position: 43.9% above the Medical Diagnostics & Research median (#74 of 215)
No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
74GF Score
Get the complete analysis for SHC
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHC has been successfully added to your 
